30 | | - | FOR the purpose of establishing a Parkinson’s Disease Registry in the Maryland 4 |
---|
31 | | - | Department of Health; requiring the Department to collect certain data for the 5 |
---|
32 | | - | Registry; authorizing the Department to share certain information in the Registry 6 |
---|
33 | | - | with certain entities under certain conditions; providing for the confidentiality of 7 |
---|
34 | | - | information collected under this Act; requiring the Department to maintain a record 8 |
---|
35 | | - | of individuals granted access to confidential information in the Registry; altering the 9 |
---|
36 | | - | duties of the Parkinson’s Disease Registry Advisory Committee; requiring the 10 |
---|
37 | | - | Committee to meet on a certain basis beginning on a certain date, rather than with 11 |
---|
38 | | - | the frequency established by the Secretary of Health; requiring the Maryland 12 |
---|
39 | | - | Department of Health, in collaboration with the State –designated health 13 |
---|
40 | | - | information exchange, to establish and maintain a certain website that has certain 14 |
---|
41 | | - | information related to Parkinson’s disease; and generally relating to the 15 |
---|
42 | | - | establishment of a Parkinson’s Disease Registry Parkinson’s disease. 16 |
---|
| 20 | + | FOR the purpose of establishing a Parkinson’s Disease Registry in the Maryland 3 |
---|
| 21 | + | Department of Health; requiring the Department to collect certain data for the 4 |
---|
| 22 | + | Registry; authorizing the Department to share certain information in the Registry 5 |
---|
| 23 | + | with certain entities under certain conditions; providing for the confidentiality of 6 |
---|
| 24 | + | information collected under this Act; requiring the Department to maintain a record 7 |
---|
| 25 | + | of individuals granted access to confidential information in the Registry; and 8 |
---|
| 26 | + | generally relating to the establishment of a Parkinson’s Disease Registry. 9 |
---|
44 | | - | BY repealing and reenacting, without amendments, 17 |
---|
45 | | - | Article – Health – General 18 |
---|
46 | | - | Section 18–1202 19 |
---|
47 | | - | Annotated Code of Maryland 20 |
---|
48 | | - | (2019 Replacement Volume and 2022 Supplement) 21 2 HOUSE BILL 703 |
---|
| 28 | + | BY repealing and reenacting, with amendments, 10 |
---|
| 29 | + | Article – Health – General 11 |
---|
| 30 | + | Section 18–1201 and 18–1203 12 |
---|
| 31 | + | Annotated Code of Maryland 13 |
---|
| 32 | + | (2019 Replacement Volume and 2022 Supplement) 14 |
---|
| 33 | + | |
---|
| 34 | + | BY repealing 15 |
---|
| 35 | + | Article – Health – General 16 |
---|
| 36 | + | Section 18–1202 17 |
---|
| 37 | + | Annotated Code of Maryland 18 |
---|
| 38 | + | (2019 Replacement Volume and 2022 Supplement) 19 |
---|
| 39 | + | |
---|
| 40 | + | BY adding to 20 |
---|
| 41 | + | Article – Health – General 21 |
---|
| 42 | + | Section 18–1202 and 18–1204 through 18–1210 22 |
---|
| 43 | + | Annotated Code of Maryland 23 |
---|
| 44 | + | (2019 Replacement Volume and 2022 Supplement) 24 |
---|
| 45 | + | |
---|
| 46 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25 |
---|
| 47 | + | That the Laws of Maryland read as follows: 26 |
---|
| 48 | + | 2 HOUSE BILL 703 |
---|
| 49 | + | |
---|
| 50 | + | |
---|
| 51 | + | Article – Health – General 1 |
---|
| 52 | + | |
---|
| 53 | + | 18–1201. 2 |
---|
| 54 | + | |
---|
| 55 | + | (a) In this subtitle the following words have the meanings indicated. 3 |
---|
| 56 | + | |
---|
| 57 | + | (b) “Advisory Committee” means the Parkinson’s Disease Registry Advisory 4 |
---|
| 58 | + | Committee. 5 |
---|
| 59 | + | |
---|
| 60 | + | (c) (1) “PARKINSONISMS ” MEANS CONDITIONS RELATED TO 6 |
---|
| 61 | + | PARKINSON’S DISEASE THAT CAUSE A COMBINATION OF THE MOVEMENT 7 |
---|
| 62 | + | ABNORMALITIES SEEN I N PARKINSON’S DISEASE. 8 |
---|
| 63 | + | |
---|
| 64 | + | (2) “PARKINSONISMS ” INCLUDES MULTIPLE SYSTEM ATROPHY, 9 |
---|
| 65 | + | DEMENTIA WITH LEWY BODIES, CORTICOBASAL DEGENERATION , AND PROGRESSIVE 10 |
---|
| 66 | + | SUPRANUCLEAR PALSY. 11 |
---|
| 67 | + | |
---|
| 68 | + | (D) “Parkinson’s disease” means a chronic and progressive disorder resulting from 12 |
---|
| 69 | + | deficiency of the neurotransmitter dopamine as the consequence of specific degenerative 13 |
---|
| 70 | + | changes in the area of the brain called the basal ganglia, characterized by tremors at rest, 14 |
---|
| 71 | + | slow movements, muscle rigidity, stooped posture, and unsteady or shuffling gait. 15 |
---|
| 72 | + | |
---|
| 73 | + | (E) “REGISTRY” MEANS THE PARKINSON’S DISEASE REGISTRY. 16 |
---|
| 74 | + | |
---|
| 75 | + | [18–1202. 17 |
---|
| 76 | + | |
---|
| 77 | + | There is a Parkinson’s Disease Registry Advisory Committee in the Department.] 18 |
---|
| 78 | + | |
---|
| 79 | + | 18–1202. 19 |
---|
| 80 | + | |
---|
| 81 | + | THERE IS A PARKINSON’S DISEASE REGISTRY IN THE DEPARTMENT . 20 |
---|
| 82 | + | |
---|
| 83 | + | 18–1203. 21 |
---|
| 84 | + | |
---|
| 85 | + | (A) THERE IS A PARKINSON’S DISEASE REGISTRY ADVISORY COMMITTEE 22 |
---|
| 86 | + | IN THE DEPARTMENT . 23 |
---|
| 87 | + | |
---|
| 88 | + | [(a)] (B) The Advisory Committee shall: 24 |
---|
| 89 | + | |
---|
| 90 | + | (1) Assist in the development and implementation of a Parkinson’s Disease 25 |
---|
| 91 | + | Registry; 26 |
---|
| 92 | + | |
---|
| 93 | + | (2) Determine what data shall be collected and be stored in a Parkinson’s 27 |
---|
| 94 | + | Disease Registry and the methods to ensure the privacy and confidentiality of data collected 28 |
---|
| 95 | + | and stored in the registry; and 29 HOUSE BILL 703 3 |
---|
109 | | - | (A) THERE IS A PARKINSON’S DISEASE REGISTRY ADVISORY COMMITTEE 6 |
---|
110 | | - | IN THE DEPARTMENT . 7 |
---|
111 | | - | |
---|
112 | | - | [(a)] (B) The Advisory Committee shall: 8 |
---|
113 | | - | |
---|
114 | | - | (1) Assist in the development and implementation of a STATE Parkinson’s 9 |
---|
115 | | - | Disease Registry; 10 |
---|
116 | | - | |
---|
117 | | - | (2) Determine what data shall be collected and be stored in a STATE 11 |
---|
118 | | - | Parkinson’s Disease Registry and the methods to ensure the privacy and confidentiality of 12 |
---|
119 | | - | data collected and stored in the registry; and 13 |
---|
120 | | - | |
---|
121 | | - | (3) Advise the Department on Parkinson’s disease and maintaining a 14 |
---|
122 | | - | STATE Parkinson’s Disease Registry; AND 15 |
---|
123 | | - | |
---|
124 | | - | (4) CONSULT WITH ENTITIES THAT MAY BE ABLE TO COLLECT DATA 16 |
---|
125 | | - | AND WORK IN PARTNERS HIP WITH THE FEDERAL CENTERS FOR DISEASE CONTROL 17 |
---|
126 | | - | AND PREVENTION TO AID THE FEDERAL CENTERS FOR DISEASE CONTROL AND 18 |
---|
127 | | - | PREVENTION IN CREATIN G A NATIONAL PARKINSON’S DISEASE REGISTRY. 19 |
---|
128 | | - | |
---|
129 | | - | (B) ENTITIES THAT MAY BE CONSULTED UNDER SUBS ECTION (A)(4) OF THIS 20 |
---|
130 | | - | SECTION INCLUDE : 21 |
---|
131 | | - | |
---|
132 | | - | (1) THE STATE–DESIGNATED HEALTH IN FORMATION EXCHANGE ; 22 |
---|
133 | | - | |
---|
134 | | - | (2) NONPROFIT ORGANIZATIO NS; AND 23 |
---|
135 | | - | |
---|
136 | | - | (3) COLLEGES OR UNIVERSIT IES. 24 |
---|
137 | | - | |
---|
138 | | - | [(b)] (C) (1) The Secretary shall appoint individuals to serve on the Advisory 25 |
---|
139 | | - | Committee, including: 26 |
---|
140 | | - | |
---|
141 | | - | (i) A neurologist; 27 |
---|
142 | | - | |
---|
143 | | - | (ii) A movement disorder specialist; 28 4 HOUSE BILL 703 |
---|
| 142 | + | (B) THE ADVISORY COMMITTEE, IN CONSULTATION WITH THE 26 |
---|
| 143 | + | DEPARTMENT , SHALL: 27 4 HOUSE BILL 703 |
---|
191 | | - | (II) DIAGNOSES; AND 27 HOUSE BILL 703 5 |
---|
| 204 | + | (D) THE DEPARTMENT MAY : 10 |
---|
| 205 | + | |
---|
| 206 | + | (1) CREATE, REVIEW, AND REVISE A LIST OF DATA POINTS REQUIRED 11 |
---|
| 207 | + | AS PART OF MANDATED PARKINSON’S DISEASE REPORTING UNDER THIS SECTION , 12 |
---|
| 208 | + | INCLUDING NECESSARY TRIGGERING DIAGNOSTI C CONDITIONS THAT AR E 13 |
---|
| 209 | + | CONSISTENT WITH THE LATEST INTERNATIONAL STATISTICAL CLASSIFICATION OF 14 |
---|
| 210 | + | DISEASES AND RELATED HEALTH PROBLEMS; AND 15 |
---|
| 211 | + | |
---|
| 212 | + | (2) IMPLEMENT THE COLLECT ION OF DATA POINTS O N THE LIST 16 |
---|
| 213 | + | CREATED UNDER ITEM (1) OF THIS SUBSECTION T HROUGH A BULLETIN , OR SIMILAR 17 |
---|
| 214 | + | INSTRUCTION, TO NURSE PRACTITIONE RS, PHYSICIANS, AND PHYSICIAN 18 |
---|
| 215 | + | ASSISTANTS. 19 |
---|
| 216 | + | |
---|
| 217 | + | (E) AT LEAST 180 DAYS BEFORE THE DEPARTMENT ADOPTS MANDA TORY 20 |
---|
| 218 | + | REPORTING OF PARKINSON’S DISEASE AND RELATE D PARKINSONISMS , THE 21 |
---|
| 219 | + | DEPARTMENT SHALL PROV IDE NOTIFICATION OF THE MANDATORY REPORT ING OF 22 |
---|
| 220 | + | PARKINSON’S DISEASE AND RELATE D PARKINSONISMS : 23 |
---|
| 221 | + | |
---|
| 222 | + | (1) ON THE DEPARTMENT ’S WEBSITE; 24 |
---|
| 223 | + | |
---|
| 224 | + | (2) DIRECTLY TO ASSOCIATIONS REPR ESENTING HOSPITALS , 25 |
---|
| 225 | + | HEALTH CARE PROFESSI ONALS, AND OTHER HEALTH CAR E PROVIDERS IN THE 26 |
---|
| 226 | + | STATE; AND 27 |
---|
| 227 | + | |
---|
| 228 | + | (3) DIRECTLY TO THE STATE BOARD OF NURSING AND THE STATE 28 |
---|
| 229 | + | BOARD OF PHYSICIANS. 29 |
---|
| 230 | + | |
---|
| 231 | + | (F) (1) A NURSE PRACTITIONER , PHYSICIAN, OR PHYSICIAN AS SISTANT 30 |
---|
| 232 | + | WHO DIAGNOSES PATIEN TS WITH PARKINSON’S DISEASE AND RELATE D 31 |
---|
| 233 | + | PARKINSONISMS SHALL REPORT EACH CASE OF PARKINSON’S DISEASE AND 32 6 HOUSE BILL 703 |
---|
| 234 | + | |
---|
| 235 | + | |
---|
| 236 | + | RELATED PARKINSONISM S TO THE REGISTRY IN A FORMAT DETERMINED BY THE 1 |
---|
| 237 | + | DEPARTMENT . 2 |
---|
| 238 | + | |
---|
| 239 | + | (2) THE DEPARTMENT MAY U SE EXISTING REPORTING PROCEDURES 3 |
---|
| 240 | + | TO IMPLEMENT THE REQ UIREMENT UNDER PARAG RAPH (1) OF THIS SUBSECTION 4 |
---|
| 241 | + | FOR DIAGNOSIS REPORT ING AND DATA SUBMISS ION BY A NURSE PRACTITIONER , 5 |
---|
| 242 | + | PHYSICIAN, OR PHYSICIAN ASSISTA NT. 6 |
---|
| 243 | + | |
---|
| 244 | + | 18–1206. 7 |
---|
| 245 | + | |
---|
| 246 | + | (A) THE DEPARTMENT MAY ENTER INTO AGREEMENTS TO P ROVIDE DATA 8 |
---|
| 247 | + | COLLECTED IN THE REGISTRY WITH PARKINSON’S DISEASE REGISTRIES IN OTHER 9 |
---|
| 248 | + | STATES, FEDERAL PARKINSON’S DISEASE CONTROL AG ENCIES, LOCAL HEALTH 10 |
---|
| 249 | + | DEPARTMENTS , OR HEALTH RESEARCHER S FOR THE STUDY OF PARKINSON’S 11 |
---|
| 250 | + | DISEASE AND RELATED PARKINSONISMS . 12 |
---|
| 251 | + | |
---|
| 252 | + | (B) (1) BEFORE CONFIDENTIAL I NFORMATION IS DISCLO SED UNDER 13 |
---|
| 253 | + | SUBSECTION (A) OF THIS SECTION , THE DEPARTMENT SHALL RECE IVE A WRITTEN 14 |
---|
| 254 | + | AGREEMENT FROM THE P ARTNERING ENTITY TO MAINTAIN THE CONFIDE NTIALITY 15 |
---|
| 255 | + | OF THE INFORMATION . 16 |
---|
| 256 | + | |
---|
| 257 | + | (2) IF THE ENTITY RECEIVI NG CONFIDENTIAL DATA FROM THE 17 |
---|
| 258 | + | REGISTRY IS A RESEARC H ENTITY, THE RESEARCH ENTITY SHALL: 18 |
---|
| 259 | + | |
---|
| 260 | + | (I) OBTAIN APPROVAL FROM THE COMMITTEE AT THE 19 |
---|
| 261 | + | RESEARCH ENTITY THAT NORMALLY REVIEW S RESEARCH PROJECTS FOR THE 20 |
---|
| 262 | + | PROTECTION OF HUMAN SUBJECTS ESTABLISHED IN ACCORDANCE WITH TITLE 45 21 |
---|
| 263 | + | OF THE CODE OF FEDERAL REGULATIONS; AND 22 |
---|
| 264 | + | |
---|
| 265 | + | (II) PROVIDE DOCUMENTATION TO THE DEPARTMENT THAT 23 |
---|
| 266 | + | DEMONSTRATES , TO THE DEPARTMENT ’S SATISFACTION , THAT THE RESEARCH 24 |
---|
| 267 | + | ENTITY HAS ESTABLISH ED PROCEDURES AND TH E ABILITY TO MAINTAI N THE 25 |
---|
| 268 | + | CONFIDENTIALITY OF T HE DISCLOSED INFORMATION . 26 |
---|
| 269 | + | |
---|
| 270 | + | (C) THE DEPARTMENT SHALL ESTA BLISH PROCEDURES TO REVIEW AND 27 |
---|
| 271 | + | APPROVE REQUESTS TO USE REGISTRY DATA FOR SCI ENTIFIC RESEARCH . 28 |
---|
| 272 | + | |
---|
| 273 | + | 18–1207. 29 |
---|
| 274 | + | |
---|
| 275 | + | (A) NOTWITHSTANDING ANY O THER PROVISION OF LA W OR RULE OF 30 |
---|
| 276 | + | PROCEDURE OR EVIDENC E IN THE MARYLAND RULES: 31 |
---|
| 277 | + | |
---|
| 278 | + | (1) A DATA DISCLOSURE AUTH ORIZED BY THIS SUBTI TLE MAY NOT: 32 HOUSE BILL 703 7 |
---|
238 | | - | |
---|
239 | | - | 1. SHALL RECORD AN INCID ENCE OF A PATIENT WI TH 1 |
---|
240 | | - | PARKINSON’S DISEASE; AND 2 |
---|
241 | | - | |
---|
242 | | - | 2. MAY NOT RECORD ANY AD DITIONAL INFORMATION 3 |
---|
243 | | - | ABOUT THE INDIVIDUAL . 4 |
---|
244 | | - | |
---|
245 | | - | (D) THE DEPARTMENT MAY : 5 |
---|
246 | | - | |
---|
247 | | - | (1) CREATE, REVIEW, AND REVISE A LIST OF DATA POINT S REQUIRED 6 |
---|
248 | | - | AS PART OF MANDATED PARKINSON’S DISEASE REPORTING UNDER THIS SECTION , 7 |
---|
249 | | - | INCLUDING NECESSARY TRIGGERING DIAGNOSTI C CONDITIONS THAT AR E 8 |
---|
250 | | - | CONSISTENT WITH THE LATEST INTERNATIONAL STATISTICAL CLASSIFICATION OF 9 |
---|
251 | | - | DISEASES AND RELATED HEALTH PROBLEMS; AND 10 |
---|
252 | | - | |
---|
253 | | - | (2) IMPLEMENT THE COLLECT ION OF DATA POINTS O N THE LIST 11 |
---|
254 | | - | CREATED UNDER ITEM (1) OF THIS SUBSECTION T HROUGH A BULLETIN , OR SIMILAR 12 |
---|
255 | | - | INSTRUCTION, TO NURSE PRACTITIONE RS, PHYSICIANS, AND PHYSICIAN 13 |
---|
256 | | - | ASSISTANTS. 14 |
---|
257 | | - | |
---|
258 | | - | (E) AT LEAST 180 DAYS BEFOR E THE DEPARTMENT ADOPTS MAN DATORY 15 |
---|
259 | | - | REPORTING OF PARKINSON’S DISEASE AND RELATE D PARKINSONISMS , THE 16 |
---|
260 | | - | DEPARTMENT SHALL PROV IDE NOTIFICATION OF THE MANDATORY REPORT ING OF 17 |
---|
261 | | - | PARKINSON’S DISEASE AND RELATE D PARKINSONISMS : 18 |
---|
262 | | - | |
---|
263 | | - | (1) ON THE DEPARTMENT ’S WEBSITE; 19 |
---|
264 | | - | |
---|
265 | | - | (2) DIRECTLY TO ASSOCIATI ONS REPRESENTING HOS PITALS, 20 |
---|
266 | | - | HEALTH CARE PROFESSI ONALS, AND OTHER HEALTH CAR E PROVIDERS IN THE 21 |
---|
267 | | - | STATE; AND 22 |
---|
268 | | - | |
---|
269 | | - | (3) DIRECTLY TO THE STATE BOARD OF NURSING AND THE STATE 23 |
---|
270 | | - | BOARD OF PHYSICIANS. 24 |
---|
271 | | - | |
---|
272 | | - | (F) (1) A NURSE PRACTITIONER , PHYSICIAN, OR PHYSICIAN ASSISTANT 25 |
---|
273 | | - | WHO DIAGNOSES PATIEN TS WITH PARKINSON’S DISEASE AND RELATE D 26 |
---|
274 | | - | PARKINSONISMS SHALL REPORT EACH CASE OF PARKINSON’S DISEASE AND 27 |
---|
275 | | - | RELATED PARKINSONISM S TO THE REGISTRY IN A FORMAT DETERMINED BY THE 28 |
---|
276 | | - | DEPARTMENT . 29 |
---|
277 | | - | |
---|
278 | | - | (2) THE DEPARTMENT MAY USE EX ISTING REPORTING PROCED URES 30 |
---|
279 | | - | TO IMPLEMENT THE REQ UIREMENT UNDER PARAG RAPH (1) OF THIS SUBSECTION 31 |
---|
280 | | - | FOR DIAGNOSIS REPORT ING AND DATA SUBMISS ION BY A NURSE PRACT ITIONER, 32 |
---|
281 | | - | PHYSICIAN, OR PHYSICIAN ASSISTA NT. 33 |
---|
282 | | - | HOUSE BILL 703 7 |
---|
283 | | - | |
---|
284 | | - | |
---|
285 | | - | 18–1206. 1 |
---|
286 | | - | |
---|
287 | | - | (A) THE DEPARTMENT MAY ENTER INTO AGREEMENTS TO PROVIDE DATA 2 |
---|
288 | | - | COLLECTED IN THE REGISTRY WITH PARKINSON’S DISEASE REGISTRIES IN OTHER 3 |
---|
289 | | - | STATES, FEDERAL PARKINSON’S DISEASE CONTROL AG ENCIES, LOCAL HEALTH 4 |
---|
290 | | - | DEPARTMENTS , OR HEALTH RESEARCHER S FOR THE STUDY OF PARKINSON’S 5 |
---|
291 | | - | DISEASE AND RELATED PARKINSONISMS . 6 |
---|
292 | | - | |
---|
293 | | - | (B) (1) BEFORE CONFIDENTIAL I NFORMATION IS DISCLO SED UNDER 7 |
---|
294 | | - | SUBSECTION (A) OF THIS SECTION , THE DEPARTMENT SHALL RECE IVE A WRITTEN 8 |
---|
295 | | - | AGREEMENT FROM THE P ARTNERING ENTITY TO MAINTAIN THE CONFIDE NTIALITY 9 |
---|
296 | | - | OF THE INFORMATION . 10 |
---|
297 | | - | |
---|
298 | | - | (2) IF THE ENTITY RECEIVI NG CONFIDE NTIAL DATA FROM THE 11 |
---|
299 | | - | REGISTRY IS A RESEARC H ENTITY, THE RESEARCH ENTITY SHALL: 12 |
---|
300 | | - | |
---|
301 | | - | (I) OBTAIN APPROVAL FROM THE COMMITTEE AT THE 13 |
---|
302 | | - | RESEARCH ENTITY THAT NORMALLY REVIEWS RES EARCH PROJECTS FOR T HE 14 |
---|
303 | | - | PROTECTION OF HUMAN SUBJECTS ESTABLISHED IN ACCORDANCE WITH TITLE 45 15 |
---|
304 | | - | OF THE CODE OF FEDERAL REGULATIONS; AND 16 |
---|
305 | | - | |
---|
306 | | - | (II) PROVIDE DOCUMENTATION TO THE DEPARTMENT THAT 17 |
---|
307 | | - | DEMONSTRATES , TO THE DEPARTMENT ’S SATISFACTION , THAT THE RESEARCH 18 |
---|
308 | | - | ENTITY HAS ESTABLISH ED PROCEDURES AND TH E ABILITY TO MAINTAI N THE 19 |
---|
309 | | - | CONFIDENTIALITY OF T HE DISCLOSED INFORMAT ION. 20 |
---|
310 | | - | |
---|
311 | | - | (C) THE DEPARTMENT SHALL ESTA BLISH PROCEDURES TO REVIEW AND 21 |
---|
312 | | - | APPROVE REQUESTS TO USE REGISTRY DATA FOR SCI ENTIFIC RESEARCH . 22 |
---|
313 | | - | |
---|
314 | | - | 18–1207. 23 |
---|
315 | | - | |
---|
316 | | - | (A) NOTWITHSTANDING ANY O THER PROVISION OF LA W OR RULE OF 24 |
---|
317 | | - | PROCEDURE OR EVIDENC E IN THE MARYLAND RULES: 25 |
---|
318 | | - | |
---|
319 | | - | (1) A DATA DISCLOSURE AUTH ORIZED BY THIS SUBTI TLE MAY NOT: 26 |
---|
320 | | - | |
---|
321 | | - | (I) INCLUDE INFORMATION O THER THAN THE INFORM ATION 27 |
---|
322 | | - | NECESSARY FOR THE PU RPOSE OF THE DISCLOS URE; 28 |
---|
323 | | - | |
---|
324 | | - | (II) BE USED FOR A PURPOSE OTHER THAN THE PURPO SE FOR 29 |
---|
325 | | - | THE DISCLOSURE ; OR 30 |
---|
326 | | - | |
---|
327 | | - | (III) BE FURTHER DISCLOSED ; 31 |
---|
328 | | - | 8 HOUSE BILL 703 |
---|
329 | | - | |
---|
330 | | - | |
---|
331 | | - | (2) THE CONFIDENTIAL INFO RMATION COLLECTED FO R THE 1 |
---|
332 | | - | REGISTRY MAY NOT BE M ADE AVAILABLE FOR SU BPOENA, DISCLOSED, 2 |
---|
333 | | - | DISCOVERABLE , OR COMPELLED TO BE P RODUCED IN ANY CIVIL , CRIMINAL, 3 |
---|
334 | | - | ADMINISTRATIVE , OR OTHER PROCEEDING ; AND 4 |
---|
335 | | - | |
---|
336 | | - | (3) THE CONFIDENTIAL INFO RMATION COLLECTED FO R THE 5 |
---|
337 | | - | REGISTRY MAY NOT BE D EEMED ADMISSIBLE AS EVIDENCE IN ANY CIVI L, CRIMINAL, 6 |
---|
338 | | - | ADMINISTRATIVE , TRIBUNAL, OR OTHER PROCEEDING . 7 |
---|
339 | | - | |
---|
340 | | - | (B) (1) THIS SECTION DOES NOT PREEMPT THE AUTHORIT Y OF A HEALTH 8 |
---|
341 | | - | CARE PROVIDER , AS DEFINED IN § 19–132 OF THIS ARTICLE , PROVIDING 9 |
---|
342 | | - | DIAGNOSTIC SERVICES OR TREATMENT TO PATI ENTS WITH PARKINSON’S DISEASE 10 |
---|
343 | | - | OR RELATED PARKINSON ISMS TO MAINTAIN A PARKINSON’S DISEASE REGISTRY . 11 |
---|
344 | | - | |
---|
345 | | - | (2) THIS SECTION DOES NOT PROHIBIT THE PUBLICA TION OF 12 |
---|
346 | | - | REPORTS AND S TATISTICAL COMPILATI ONS THAT DO NOT IDEN TIFY INDIVIDUALS 13 |
---|
347 | | - | WITH PARKINSON’S DISEASE OR RELATED PARKINSONISMS OR IND IVIDUAL 14 |
---|
348 | | - | SOURCES OF INFORMATI ON. 15 |
---|
349 | | - | |
---|
350 | | - | 18–1208. 16 |
---|
351 | | - | |
---|
352 | | - | (A) THE DEPARTMENT SHALL MAIN TAIN A RECORD OF IND IVIDUALS 17 |
---|
353 | | - | GRANTED ACCESS TO CO NFIDENTIAL INFORMATION FROM THE REGISTRY. 18 |
---|
354 | | - | |
---|
355 | | - | (B) THE DEPARTMENT MAY NOT DE NY A REQUEST FOR INS PECTION OF THE 19 |
---|
356 | | - | RECORD MAINTAINED UN DER SUBSECTION (A) OF THIS SECTION UNDE R TITLE 4 OF 20 |
---|
357 | | - | THE GENERAL PROVISIONS ARTICLE. 21 |
---|
358 | | - | |
---|
359 | | - | (C) THE RECORD MAINTAINED UNDER SUBSECTION (A) OF THIS SECTION 22 |
---|
360 | | - | SHALL INCLUDE THE AC CESSING INDIVIDUAL ’S: 23 |
---|
361 | | - | |
---|
362 | | - | (1) NAME; 24 |
---|
363 | | - | |
---|
364 | | - | (2) TITLE; 25 |
---|
365 | | - | |
---|
366 | | - | (3) ADDRESS; 26 |
---|
367 | | - | |
---|
368 | | - | (4) ORGANIZATIONAL AFFILI ATION; 27 |
---|
369 | | - | |
---|
370 | | - | (5) DATES OF ACCESS; AND 28 |
---|
371 | | - | |
---|
372 | | - | (6) PURPOSE FOR ACCESSING THE INFORMATION . 29 |
---|
373 | | - | |
---|
374 | | - | 18–1209. 30 HOUSE BILL 703 9 |
---|
| 323 | + | (2) TITLE; 30 8 HOUSE BILL 703 |
---|
410 | | - | (III) SEX; 23 |
---|
411 | | - | |
---|
412 | | - | (IV) RACE; 24 |
---|
413 | | - | |
---|
414 | | - | (V) ETHNICITY; AND 25 |
---|
415 | | - | |
---|
416 | | - | (VI) CASES BY COUNTY . 26 |
---|
417 | | - | |
---|
418 | | - | (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 27 |
---|
419 | | - | SHALL: 28 |
---|
420 | | - | 10 HOUSE BILL 703 |
---|
421 | | - | |
---|
422 | | - | |
---|
423 | | - | (1) INCLUDE THE DATA AVAI LABLE FOR THE 5–YEAR PERIOD ENDING 1 |
---|
424 | | - | ON SEPTEMBER 30, 2023; AND 2 |
---|
425 | | - | |
---|
426 | | - | (2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR, TO INCLUDE 3 |
---|
427 | | - | ANY NEWLY AVAILABLE DATA. 4 |
---|
428 | | - | |
---|
429 | | - | SECTION 2. AND BE IT FURTHER ENACTED, That on or before July 1, 2024, the 5 |
---|
430 | | - | Parkinson’s Disease Registry Advisory Committee shall report to the Senate Finance 6 |
---|
431 | | - | Committee and the House Health and Government Operations Committee, in accordance 7 |
---|
432 | | - | with § 2–1257 of the State Government Article, on recommendations for a path forward 8 |
---|
433 | | - | toward the establishment of a fully functional State Parkinson’s Disease Registry. 9 |
---|
434 | | - | |
---|
435 | | - | SECTION 3. AND BE IT FURTHER ENACTED, That the Maryland Department of 10 |
---|
436 | | - | Health shall establish the website required under § 18–1204 of the Health – General 11 |
---|
437 | | - | Article, as enacted by Section 1 of this Act, on or before October 1, 2023. 12 |
---|
438 | | - | |
---|
439 | | - | SECTION 2. 4. AND BE IT FURTHER ENACTED, That this Act shall take effect 13 |
---|
440 | | - | October June 1, 2023. 14 |
---|
441 | | - | |
---|
442 | | - | |
---|
443 | | - | |
---|
444 | | - | |
---|
445 | | - | Approved: |
---|
446 | | - | ________________________________________________________________________________ |
---|
447 | | - | Governor. |
---|
448 | | - | ________________________________________________________________________________ |
---|
449 | | - | Speaker of the House of Delegates. |
---|
450 | | - | ________________________________________________________________________________ |
---|
451 | | - | President of the Senate. |
---|